
http://paratekpharma.com
Paratek Pharmaceuticals, Inc. Company Intro
Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions.
Industry
Healthcare
Paratek Pharmaceuticals, Inc. Headquaters
75 Park Plaza
Boston,02116
United States
Paratek Pharmaceuticals, Inc. Share price
15 Jan 2021 02:23 GMT
$6.80
0.16 (2.41 %)
Paratek Pharmaceuticals, Inc. Market cap
$307.622 M
WMC RANKING
2021
Paratek Pharmaceuticals, Inc. # 118
BiotechnologyLatest Paratek Pharmaceuticals, Inc. News
09 Jan 2021
Zacks: Analysts Expect Paratek Pharmaceuticals, Inc ...
Equities analysts predict that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) will report earnings of $0.08 per share for the current fiscal quarter, according to ...
09 Jan 2021
Zacks: Analysts Expect Paratek Pharmaceuticals, Inc ...
Equities analysts predict that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) will report earnings of $0.08 per share for the current fiscal quarter, according to ...
09 Jan 2021
Zacks: Analysts Expect Paratek Pharmaceuticals, Inc ...
Equities analysts predict that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) will report earnings of $0.08 per share for the current fiscal quarter, according to ...
WMC Market Score
WMC Market to Revenue Score
Paratek Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Paratek Pharmaceuticals, Inc. | USD | $39,870 | $113,544 | $-98,896 | $3,076M | 118 |
Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,640B | 1 |
Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,630B | 2 |
Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $588,000B | 3 |
ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $279,490B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Paratek Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Paratek Pharmaceuticals, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Paratek Pharmaceuticals, Inc. | 0.43 | 14.16 | 9.43 | 0 | 0 | 0 | 12.17 |
Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge